QuidelOrtho Corporation (QDEL) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism led by a solid first-quarter 2024 performance and its continued spending on research and development (R&D) are expected to contribute further. However, headwinds due to data security threats and reimbursement policies persist.Over the past year, this Zacks Rank #3 (Hold) stock has lost 60% compared with a 2.2% decline of the industry. The S&P 500 has witnessed 23% growth in ...